Artelo Biosciences's total assets for Q3 2025 were $4.27M, a decrease of -2.07% from the previous quarter. ARTL total liabilities were $4.90M for the fiscal quarter, a -14.97% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.